134 related articles for article (PubMed ID: 12540021)
1. Elevated plasma levels of vascular endothelial growth factor and plasminogen activator inhibitor-1 decrease during improvement of psoriasis.
Nielsen HJ; Christensen IJ; Svendsen MN; Hansen U; Werther K; Brünner N; Petersen LJ; Kristensen JK
Inflamm Res; 2002 Nov; 51(11):563-7. PubMed ID: 12540021
[TBL] [Abstract][Full Text] [Related]
2. Elevated vascular endothelial growth factor in systemic sclerosis.
Choi JJ; Min DJ; Cho ML; Min SY; Kim SJ; Lee SS; Park KS; Seo YI; Kim WU; Park SH; Cho CS
J Rheumatol; 2003 Jul; 30(7):1529-33. PubMed ID: 12858453
[TBL] [Abstract][Full Text] [Related]
3. Levels of endothelial cell stimulating angiogenesis factor and vascular endothelial growth factor are elevated in psoriasis.
Bhushan M; McLaughlin B; Weiss JB; Griffiths CE
Br J Dermatol; 1999 Dec; 141(6):1054-60. PubMed ID: 10606852
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of vascular endothelial growth factor dependent on the stage progression of lung cancer.
Matsuyama W; Hashiguchi T; Mizoguchi A; Iwami F; Kawabata M; Arimura K; Osame M
Chest; 2000 Oct; 118(4):948-51. PubMed ID: 11035661
[TBL] [Abstract][Full Text] [Related]
5. Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers.
Distler O; Del Rosso A; Giacomelli R; Cipriani P; Conforti ML; Guiducci S; Gay RE; Michel BA; Brühlmann P; Müller-Ladner U; Gay S; Matucci-Cerinic M
Arthritis Res; 2002; 4(6):R11. PubMed ID: 12453314
[TBL] [Abstract][Full Text] [Related]
6. Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer.
Lin SY; Wang YY; Sheu WH
Clin Endocrinol (Oxf); 2003 Apr; 58(4):513-8. PubMed ID: 12641636
[TBL] [Abstract][Full Text] [Related]
7. Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management.
Felmeden DC; Spencer CG; Belgore FM; Blann AD; Beevers DG; Lip GY
Am J Hypertens; 2003 Jan; 16(1):11-20. PubMed ID: 12517677
[TBL] [Abstract][Full Text] [Related]
8. Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
Aguayo A; Kantarjian HM; Estey EH; Giles FJ; Verstovsek S; Manshouri T; Gidel C; O'Brien S; Keating MJ; Albitar M
Cancer; 2002 Nov; 95(9):1923-30. PubMed ID: 12404286
[TBL] [Abstract][Full Text] [Related]
9. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
[TBL] [Abstract][Full Text] [Related]
10. Increased serum levels of vascular endothelial growth factor correlate with splenomegaly in polycythemia vera.
Murphy P; Ahmed N; Hassan HT
Leuk Res; 2002 Nov; 26(11):1007-1010. PubMed ID: 12363469
[TBL] [Abstract][Full Text] [Related]
11. Measurement of the soluble angiopoietin receptor tie-2 in patients with coronary artery disease: development and application of an immunoassay.
Chung NA; Makin AJ; Lip GY
Eur J Clin Invest; 2003 Jul; 33(7):529-35. PubMed ID: 12814387
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of uPA, PAI-1, HER-2 and VEGF in the serum of ovarian cancer patients.
Abendstein B; Daxenbichler G; Windbichler G; Zeimet AG; Geurts A; Sweep F; Marth C
Anticancer Res; 2000; 20(1B):569-72. PubMed ID: 10769727
[TBL] [Abstract][Full Text] [Related]
13. Increased angiogenic growth factor in cyanotic congenital heart disease.
Himeno W; Akagi T; Furui J; Maeno Y; Ishii M; Kosai K; Murohara T; Kato H
Pediatr Cardiol; 2003; 24(2):127-32. PubMed ID: 12360391
[TBL] [Abstract][Full Text] [Related]
14. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma.
Poon RT; Lau CP; Cheung ST; Yu WC; Fan ST
Cancer Res; 2003 Jun; 63(12):3121-6. PubMed ID: 12810638
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis in myocardial infarction. An acute or chronic process?
Chung NA; Lydakis C; Belgore F; Blann AD; Lip GY
Eur Heart J; 2002 Oct; 23(20):1604-8. PubMed ID: 12323160
[TBL] [Abstract][Full Text] [Related]
16. Blood levels of angiogenin and vascular endothelial growth factor are elevated in myelodysplastic syndromes and in acute myeloid leukemia.
Brunner B; Gunsilius E; Schumacher P; Zwierzina H; Gastl G; Stauder R
J Hematother Stem Cell Res; 2002 Feb; 11(1):119-25. PubMed ID: 11847008
[TBL] [Abstract][Full Text] [Related]
17. Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients.
Eppenberger U; Kueng W; Schlaeppi JM; Roesel JL; Benz C; Mueller H; Matter A; Zuber M; Luescher K; Litschgi M; Schmitt M; Foekens JA; Eppenberger-Castori S
J Clin Oncol; 1998 Sep; 16(9):3129-36. PubMed ID: 9738585
[TBL] [Abstract][Full Text] [Related]
18. Mediation of systemic vascular hyperpermeability in severe psoriasis by circulating vascular endothelial growth factor.
Creamer D; Allen M; Jaggar R; Stevens R; Bicknell R; Barker J
Arch Dermatol; 2002 Jun; 138(6):791-6. PubMed ID: 12056961
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor expression in serum of patients with hepatocellular carcinoma.
Zhao J; Hu J; Cai J; Yang X; Yang Z
Chin Med J (Engl); 2003 May; 116(5):772-6. PubMed ID: 12875699
[TBL] [Abstract][Full Text] [Related]
20. Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression.
Baker EA; Bergin FG; Leaper DJ
Mol Pathol; 2000 Dec; 53(6):307-12. PubMed ID: 11193049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]